Results 51 to 60 of about 710,485 (229)

Single Sign-On in Cloud Computing Scenarios: A Research Proposal [PDF]

open access: yes, 2011
Cloud computing and Software as a Service infrastructure are becoming important factors in E-commerce and E-business processes. Users may access simultaneously to different E-services supplied by several providers.
D'Atri, Edoardo   +2 more
core   +1 more source

LINC01116, a hypoxia‐lncRNA marker of pathological lymphangiogenesis and poor prognosis in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
The LINC01116 long noncoding RNA is induced by hypoxia and associated with poor prognosis and high recurrence rates in two cohorts of lung adenocarcinoma patients. Here, we demonstrate that besides its expression in cancer cells, LINC01116 is markedly expressed in lymphatic endothelial cells of the tumor stroma in which it participates in hypoxia ...
Marine Gautier‐Isola   +12 more
wiley   +1 more source

Staying Young at the Edge: A Software Aging Perspective for Foundation Models as a Service

open access: yesComputers
Nowadays, the emergence of Foundation Models as a Service enables mobile users to access powerful capabilities such as inference and fine-tuning on demand and without incurring local computational overhead.
Benedetta Picano, Romano Fantacci
doaj   +1 more source

Debesų kompiuterijos programinės įrangos paslaugų greitaveikos tyrimai / Performance analysis of cloud computing software services

open access: yesMokslas: Lietuvos Ateitis, 2019
The paper presents the performance analysis of the developed software as a service. In OpenStack cloud infrastructure, the software services for hemodynamic flow modelling and particle technology applications have been developed by using Apache jclouds ...
Oleg Bystrov   +2 more
doaj   +1 more source

Penerapan Cloud Computing Pada Website Pemesanan Kamar Kost Dengan Model Layanan Software as a Service [PDF]

open access: yes, 2013
Pesankos.com adalah sebuah sistem reservasi kamar kos berbasis web yang dibangun dengan menerapkan model layanan software as a service cloud computing.
Hartanto, A. D. (Anggit)   +1 more
core  

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon   +13 more
wiley   +1 more source

Web Single Sign-On Authentication using SAML [PDF]

open access: yes, 2009
Companies have increasingly turned to application service providers (ASPs) or Software as a Service (SaaS) vendors to offer specialized web-based services that will cut costs and provide specific and focused applications to users.
Lewis, James E., Lewis, Kelly D.
core  

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

open access: yesMolecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix   +13 more
wiley   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

open access: yesMolecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla   +10 more
wiley   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy